Showcasing Southern California's innovation, one startup at a time. Every funded and bootstrapped company, from seed round to first dollar of revenue, tracked as it happens.
Includes SEC Form D filings from the last 3 years, plus all-time totals for companies sourced from YC and news coverage.

The region's largest single cluster by company count — AI and machine learning threaded through nearly every other industry here, from defense to biotech to entertainment.

Home to SpaceX, Northrop Grumman, and a new wave of hypersonics and space-infrastructure startups.

Hollywood's production infrastructure, live events, and a growing games and creator-tools scene.

Qualcomm and Broadcom anchor a chip-design cluster spanning the region.

A deep biotech research base and a growing bench of medical device and diagnostics startups.

Business software and services sold to other companies. The largest single category of startup across Southern California, spanning sales tools, vertical operating systems, and everything in between.

Manufacturing, hardware, and physical-world operations. Overlaps heavily with the region's decades-old aerospace and defense manufacturing base, now extending into robotics and automated production.

Products and apps built directly for individual consumers, drawing on Southern California's media and entertainment base.

Health tech, medical devices, and healthcare services, backed by a decades-old biotech research base and a deep bench of clinical and diagnostics startups.

Financial technology: payments, banking, investing, and financial infrastructure.

Education technology and learning platforms built across Southern California.

Property technology, construction tech, and real estate services.

Unprecedented onchain exposure to the world's leading institutional grade private credit managers, including Ares, Apollo, and more.

Recurve helps utilities, implementers, and partners transform customer data into reliable, cost-effective demand-side programs built to perform.

Built to think like a comp expert—trained on your strategy and powered by Compa’s market data to guide every pay decision.
Founded by Wei Gan, Ph.D.; the cardiac device maker has raised over $11M, with Qiming Venture Partners among its investors.

Accelerating humanity’s galactic destiny

Syrna Therapeutics is pioneering a new class of mRNA targeting therapeutics that stop expression of disease-causing proteins

BlueNalu, Inc. develops cell-cultivated seafood, beginning with bluefin tuna toro—crafted with care and produced without fishing.
Leading the fight against cancer with targeted stem cell and viral therapies that activate the immune system to destroy solid tumors and metastatic disease.